In this episode, you’ll learn about the main side effects associated with CAR T-cell and bispecific antibody therapies, two newer multiple myeloma treatments. You’ll also hear from a patient and a nurse practitioner, who describe how these treatments are administered and share their accounts of what being on these immunotherapies is like.
(1:16) Differences between CAR T cells and autologous stem cell transplantation
(10:48) Available CAR T-cell therapies
(14:27) Available bispecific antibody therapies
(17:00) Main side effects of CAR T-cell and bispecific antibody therapies
This episode is supported by AbbVie, CURE, Genentech, Pfizer, Regeneron, and Sanofi.
To learn more about immunotherapy, view our High-Impact Topic videos here and here.
To learn more about multiple myeloma, visit www.themmrf.org.
If you want to learn more about the MMRF’s FREE resources for patients and caregivers, visit the MMRF Education Hub.
If you have additional questions, call our MMRF Patient Navigation Center at 1-888-841- 6673.
